Biosimilars and their launch price considerations
Introduction “Biosimilar” medicines are characteristically different from generic medicines because of their molecular size and structure, together with the sheer complexity and cost of their development. For example, a 500mg generic Paracetamol tablet will be identical to that of licensed manufacturers. Biosimilars are biological medicines that are similar to other existing biologic medicines already licensed
Biosimilars and their launch price considerations Read More »